Method to account for event losses due to positron range in...

Details Method to account for event losses due to positron range in... Method to account for event losses due to positron range in...

2006-01-17

2006-01-17

Porta, David (Department: 2878)

Radiant energy

Invisible radiant energy responsive electric signalling

Methods

C250S369000, C250S363030

Reexamination Certificate

active

06987270

ABSTRACT:
A method of quantitative positron emission analysis includes accounting for the loss of positron-electron annihilation events and quantitative inaccuracies in positron emission assays.

REFERENCES:
patent: 5143713 (1992-09-01), Phillips et al.
patent: 5158760 (1992-10-01), Phillips et al.
patent: 5210423 (1993-05-01), Arseneau
patent: 5310539 (1994-05-01), Williams
patent: 5792444 (1998-08-01), Fischman et al.
patent: 5792742 (1998-08-01), Gold et al.
patent: 5881178 (1999-03-01), Tsykalov et al.
patent: 6019957 (2000-02-01), Miller et al.
patent: 6024938 (2000-02-01), Corbo et al.
patent: 6426400 (2002-07-01), Zalutsky
patent: 6468505 (2002-10-01), Lang et al.
patent: 2002/0025296 (2002-02-01), Knaus et al.
patent: 2002/0098148 (2002-07-01), Miller et al.
patent: 2002/0102264 (2002-08-01), Cheung
patent: 2002/0115112 (2002-08-01), Yu et al.
patent: 2002/0173626 (2002-11-01), Kundra
patent: 2004/0225214 (2004-11-01), Trotter et al.
patent: 0 532 718 (1999-12-01), None
patent: WO 92/01068 (1992-01-01), None
patent: WO 92/18166 (1992-10-01), None
patent: WO 95/11045 (1995-04-01), None
patent: WO 96/04304 (1996-02-01), None
patent: WO 96/12508 (1996-05-01), None
patent: WO 96/40295 (1996-12-01), None
patent: WO 98/55153 (1998-12-01), None
patent: WO 99/55367 (1999-11-01), None
patent: WO 00/32240 (2000-06-01), None
patent: WO 00/69914 (2000-11-01), None
patent: WO 01/25410 (2001-04-01), None
patent: WO 01/30398 (2001-05-01), None
patent: WO 01/36003 (2001-05-01), None
patent: WO 01/36486 (2001-05-01), None
patent: WO 01/79442 (2001-10-01), None
patent: WO 02/14369 (2002-02-01), None
patent: WO 02/18620 (2002-03-01), None
patent: WO 02/32375 (2002-04-01), None
patent: WO 02/38612 (2002-05-01), None
patent: WO 02/064747 (2002-08-01), None
Gregory P. Adams, “Improving the Tumor Specificity and Retention of Antibody-Based Molecules”, in vivo 12: 11-22, (1998).
Gregory P. Adamns et al., “Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2
eu”, British Journal of Cancer (1996), 77 (9), pp. 1405-1412.
Pieter L. Jager et al., “Radiolabeled Amino Acids: Basic Aspects and Clinical Applications in Oncology”, The Journal of Nuclear Medicine, vol. 42, No. 3, Mar. 2001.
Robert M. Kessler et al., Analysis of Emission Tomographic Scan Data: Limitations Imposed by Resolution and Background, Journal of computer Assisted Tomography, 8 (3): pp. 514-522, Jun. 1984.
Richard Laforest et al., “MicroPET Imaging With Nonconventional Isotopes”, IEEE Transactions on Nuclear Science, vol. 49, No. 5, Oct. 2002.
Craig S. Levin et al., “Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution”, Phys. Med. Biol. 44 (1999), pp. 781-799.
Anna Lövqvist et al., “PET Imaging of86Y-Labeled Anti-Lewis Y Monoclonal Antibodies in a Nude Mouse Model: Comparison Between86Y and111In Radiolables”, The Journal of Nuclear Medicine, vol. 42, No. 8, Aug. 2001, pp. 1281-1287.
Ulrik B. Nielsen et al., “Targeting of Bivalent Anti-ErbB2 Diabody Antibody Fragments to Tumor Cells Is Independent of the Intrinsic Antibody Affinity1”, Cancer Research 60, pp. 6434-6440, Nov. 15, 2000.
Gabriela Pavlinkova et al., “Pharmacokinetics and Biodistribution of Engineered Single-Chain Antibody Constructs of Mab CC49 in colon Carcinoma Xenografts”, The Journal of Nuclear Medicine, vol. 40, No. 9, Sep. 1999, pp. 1536-1546.
Keith S. Pentlow et al., “Quantitative imaging of l-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy”, Med. Phys. 18 (3), May/Jun. 1991, pp. 357-366.
Keith S. Pentlow et al., “Quantitative Imaging of Yttrium-86 with PET: The Occurrence and Correction of Anomalous Apparent Activity in High Density Regions”, Clinical Positron Imaging, vol. 3, No. 3, pp. 85-90, (2000).
Timothy A.D. Smith et al., “Treatment of SW620 Cells with Tomudex and Oxaliplatin Induces Changes in 2-Deoxy-D-Glucose Incorporation Associated with Modifications in Glucose Transport”, The Journal of Nuclear Medicine, vol. 41, No. 10, pp. 1753-1759, Oct. 2000.
Anna M. Wu et al., “High-resolution microPET imaging of carcino-embryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment”, PNAS, Jul. 18, 2000, vol. 97, No. 15, pp. 8495-8500.

Affiliated with

Also associated with

Rating

Method to account for event losses due to positron range in... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method to account for event losses due to positron range in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to account for event losses due to positron range in... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3591703